8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 3, 2007

DATASCOPE CORP.

(Exact name of registrant as specified in its charter)

Delaware	0-6516	13-2529596
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

14 Philips Parkway
Montvale, New Jersey	07645-9998
(Address of principal executive offices)	(Zip Code)
(Registrant’s telephone number, including area code) (201) 391-8100

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

EX-99.1: PRESS RELEASE

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective April 3, 2007, Scott Kantor resigned as Chief Financial Officer of Datascope Corp. (the “Company”) to pursue other opportunities. In connection with the resignation, the Company and Mr. Kantor entered into a letter agreement and an Agreement and General Release (together, the “Agreements”).

Pursuant to the Agreements, the Company will pay Mr. Kantor severance equal to his base salary prior to the termination of his employment of $250,000, less deductions, over a period of one year from April 3, 2007. The Company will continue to provide medical benefits for a period of one year from April 3, 2007 or until Mr. Kantor commences full-time employment, whichever is sooner.

On April 3, 2006, the Board of Directors of the Company elected Henry Scaramelli as Acting Chief Financial Officer of the Company. Mr. Scaramelli, 53, has been employed by the Corporation as Corporate Vice President and Controller from September 2003 to the present, a position he will continue to hold. From June 2004 to the present, Mr. Scaramelli has served as Acting Vice President of Finance for the Interventional Products Division and InterVascular, Inc. From July 2002 to August 2003, Mr. Scaramelli served as Group Vice President, Finance for the Cardiac Assist Division and InterVascular, Inc. From October 1996 to June 2002, Mr. Scaramelli served as Vice President, Finance for the Cardiac Assist Division.

On April 4, 2007, the Company issued a press release announcing the matters discussed above. The press release is attached as Exhibit 99.1 to this report.

Item 9.01 Financial Statements and Exhibits

99.1 Press release dated April 4, 2007 issued by Datascope Corp.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATASCOPE CORP.
Registrant
By:	/s/ Fred Adelman
	Vice President,
	Chief Accounting Officer

Dated: April 6, 2007

EXHIBIT INDEX

99.1 Press release dated April 4, 2007 issued by Datascope Corp.

EX-99.1

Exhibit No. 99.1

PRESS RELEASE

For Information Contact:

Hank Scaramelli

Acting Chief Financial Officer

Datascope Corp.

Montvale, NJ 07645

Tel: (201) 307-5435

FOR IMMEDIATE RELEASE:

DATASCOPE ANNOUNCES RESIGNATION OF CFO;
NAMES SCARAMELLI AS REPLACEMENT

MONTVALE, NJ, APRIL 4, 2007 — Datascope Corp. (NASDAQ: DSCP) announced today that Scott Kantor resigned yesterday as Chief Financial Officer of Datascope to pursue other opportunities. Hank Scaramelli, Corporate Vice-President and Controller, will assume the position of Acting Chief Financial Officer, replacing Kantor.

Scaramelli is a 17-year veteran financial executive at Datascope. Starting as Controller of the Cardiac Assist Division, he served successively as Vice-President of Finance for that division, and was then promoted to Group Vice-President of Finance for the Cardiac Assist and InterVascular divisions. Four years ago, Scaramelli was promoted to Corporate Vice-President and Controller, a position he will continue to hold. Besides Hank Scaramelli, the top financial management team of Datascope includes Fred Adelman, Datascope’s Chief Accounting Officer since 2002, and a 28-year veteran financial executive at Datascope. Adelman will be a direct report of Scaramelli.

About Datascope Corp.

Datascope Corp. is the global leader of intra-aortic balloon counterpulsation and a diversified medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. Datascope’s products are sold throughout the world through direct sales representatives and independent distributors. Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news releases, webcasts and other Company information please visit Datascope’s website, www.datascope.com.